Ceribell (CBLL) Change in Receivables (2023 - 2026)
Ceribell (CBLL) reported Change in Receivables of $659000.0 for Q1 2026, up 56.53% on a YoY basis from $421000.0 in Q1 2025, and down 76.62% quarter-over-quarter from $2.8 million in Q4 2025.
Ceribell (CBLL) Change in Receivables (2023 - 2026) Analysis & Trends
Ceribell has reported Change in Receivables for 4 years, with the latest figure at $659000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 56.53% year-over-year to $659000.0; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 85.65% YoY), and the FY2025 full-year result was $4.2 million, up 42.83% from the prior year.
- Change in Receivables for Q1 2026 stood at $659000.0, down from $2.8 million in the prior quarter.
- The five-year high for Change in Receivables was $2.8 million in Q4 2025, with the low at -$78000.0 in Q3 2025.
- Historically, Change in Receivables has averaged $883600.0 across 4 years, with a median of $832500.0 in 2024.
- The largest YoY upside for Change in Receivables was 248.11% in 2025 against a maximum downside of 110.26% in 2025.
- Ceribell's Change in Receivables stood at $1.1 million in 2023, then slipped by 16.13% to $905000.0 in 2024, then surged by 211.49% to $2.8 million in 2025, then tumbled by 76.62% to $659000.0 in 2026.
- The last three Change in Receivables figures came in at $659000.0 (Q1 2026), $2.8 million (Q4 2025), and -$78000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Ceribell | 679.82 Mn | 538.64 Mn | 23.12 Mn | 659,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 659,000.00 |
| Mar 31, 2026 | 659,000.00 |
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Sep 30, 2025 | -78,000.00 |
| Sep 30, 2025 | -78,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 421,000.00 |
| Mar 31, 2025 | 421,000.00 |
| Dec 31, 2024 | 905,000.00 |
| Dec 31, 2024 | 905,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Jun 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 291,000.00 |
| Mar 31, 2024 | 967,000.00 |
| Mar 31, 2024 | 967,000.00 |
| Dec 31, 2023 | 1.08 Mn |
| Dec 31, 2023 | 1.08 Mn |